OCMI

Oaktop Capital Management II Portfolio holdings

AUM $930M
This Quarter Return
+28.86%
1 Year Return
+12.03%
3 Year Return
+128.14%
5 Year Return
+269.31%
10 Year Return
+745.39%
AUM
$568M
AUM Growth
+$568M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
92.48%
Holding
19
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Technology 69.16%
2 Healthcare 9.85%
3 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LRCX icon
1
Lam Research
LRCX
$127B
$149M 26.34%
316,504
– –
KLAC icon
2
KLA
KLAC
$115B
$104M 18.28%
400,750
– –
MXIM
3
DELISTED
Maxim Integrated Products
MXIM
$65.8M 11.6%
742,375
– –
ASPN icon
4
Aspen Aerogels
ASPN
$563M
$49.1M 8.65%
2,939,758
– –
BMY icon
5
Bristol-Myers Squibb
BMY
$96B
$42.2M 7.43%
679,991
– –
EGAN icon
6
eGain
EGAN
$172M
$30M 5.28%
2,536,843
– –
CEVA icon
7
CEVA Inc
CEVA
$531M
$28.7M 5.06%
631,377
– –
PRGS icon
8
Progress Software
PRGS
$2B
$27.7M 4.88%
612,526
– –
SONO icon
9
Sonos
SONO
$1.68B
$15.2M 2.68%
650,000
– –
VMW
10
DELISTED
VMware, Inc
VMW
$13M 2.29%
92,500
– –
PETS icon
11
PetMed Express
PETS
$63.4M
$12M 2.11%
373,675
– –
DELL icon
12
Dell
DELL
$82.6B
$10.3M 1.82%
140,619
– –
AVGO icon
13
Broadcom
AVGO
$1.4T
$7.01M 1.23%
16,000
– –
GRMN icon
14
Garmin
GRMN
$46.5B
$5.74M 1.01%
48,000
– –
XLE icon
15
Energy Select Sector SPDR Fund
XLE
$27.6B
$3.79M 0.67%
100,000
– –
INTC icon
16
Intel
INTC
$107B
$1.65M 0.29%
33,010
– –
AXDX
17
DELISTED
Accelerate Diagnostics
AXDX
$1.18M 0.21%
155,000
– –
ANIK icon
18
Anika Therapeutics
ANIK
$135M
$566K 0.1%
12,500
– –
BMY.RT
19
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$487K 0.09%
704,991
– –